Literature DB >> 11967649

Bradykinesia in Huntington's disease. A prospective, follow-up study.

Pedro J García Ruiz1, Jaime Hernández, Susana Cantarero, Manuel Bartolomé, Vicenta Sánchez Bernardos, Justo García de Yébenez.   

Abstract

Bradykinesia is a frequent finding in Huntington's disease (HD), but some aspects are presently unknown; including the natural evolution of bradykinesia over time and the correlation between bradykinesia and functional capacity. We studied the motor performance of 20 genetically confirmed patients with HD (age: 40+/-10.8 years; age at onset 33.6+/-11 years; total functional capacity (TFC): 9.57+/-3; UHDRS total motor scale: 31.4+/-13, triplet length (CAG)n: 46.7+/-4 triplets). These patients were studied in baseline conditions and after 18.7+/-6 months of follow-up. In addition, HD patients were compared with 20 age-matched normal controls. Motor study included the four CAPIT timed tests commonly used for Parkinson's disease: pronation-supination (PS), finger dexterity (FD), movement between two points (MTP) and walking test (WT). HD patients were significantly slower than controls in all motor tasks. A significant deterioration occurred over time in three of the four motor tasks (especially FD and WT). A significant correlation between timed tests and TFC score was found (for MTP, r: -0.845; p < 0,0001). In addition a significant correlation between timed tests and the UHDRDS total motor scale was also found (for MTP, r: 0.864; p < 0.0001). In conclusion, simple timed motor tests can detect a deterioration of motor activity over time in HD. Timed tests might be useful to follow the natural evolution of HD and to assess the efficacy of new therapies.

Entities:  

Mesh:

Year:  2002        PMID: 11967649     DOI: 10.1007/s004150200035

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Huntington's disease: changes in saccades and hand-tapping over 3 years.

Authors:  Chrystalina A Antoniades; Zheyu Xu; Sarah L Mason; R H S Carpenter; Roger A Barker
Journal:  J Neurol       Date:  2010-06-29       Impact factor: 4.849

2.  JPH3 repeat expansions cause a progressive akinetic-rigid syndrome with severe dementia and putaminal rim in a five-generation African-American family.

Authors:  Susanne A Schneider; Kate E Marshall; Jianfeng Xiao; Mark S LeDoux
Journal:  Neurogenetics       Date:  2012-03-25       Impact factor: 2.660

3.  Deficits in stepping response time are associated with impairments in balance and mobility in people with Huntington disease.

Authors:  Allon Goldberg; Stacey L Schepens; Shawna M E Feely; James Y Garbern; Lindsey J Miller; Carly E Siskind; Gerry E Conti
Journal:  J Neurol Sci       Date:  2010-11-15       Impact factor: 3.181

4.  The relationship between impairment of voluntary movements and cognitive impairment in Huntington's disease.

Authors:  Jirí Klempír; Olga Klempírová; Jan Stochl; Natasa Spacková; Jan Roth
Journal:  J Neurol       Date:  2009-05-16       Impact factor: 4.849

5.  Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington's disease.

Authors:  A W Michell; A O G Goodman; A H D Silva; S E Lazic; A J Morton; R A Barker
Journal:  J Neurol       Date:  2008-05-13       Impact factor: 4.849

6.  Atypical Parkinsonism Revealing a Late Onset, Rigid and Akinetic Form of Huntington's Disease.

Authors:  A Ciammola; J Sassone; B Poletti; N Mencacci; R Benti; V Silani
Journal:  Case Rep Neurol Med       Date:  2011-09-07

7.  Statistical characteristics of finger-tapping data in Huntington's disease.

Authors:  Chrystalina A Antoniades; Jan Ober; Stephen Hicks; Gill Siuda; R H S Carpenter; Christopher Kennard; Andrea H Nemeth
Journal:  Med Biol Eng Comput       Date:  2012-01-19       Impact factor: 2.602

8.  Motor onset and diagnosis in Huntington disease using the diagnostic confidence level.

Authors:  Dawei Liu; Jeffrey D Long; Ying Zhang; Lynn A Raymond; Karen Marder; Anne Rosser; Elizabeth A McCusker; James A Mills; Jane S Paulsen
Journal:  J Neurol       Date:  2015-09-26       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.